(UroToday.com) The ANZUP annual scientific meeting’s clinical trials session included an update in bladder and penile cancer provided by Dr. Dickon Hayne. Dr. Hayne notes that bladder cancer survival is poor in Australia (and has been getting worse over time) with a 5-year survival rate of 69% for males and 66% for females between 1982-1987, compared to 60% for males and 50% for females from 2006 to 2010. With regards to penile cancer, there is little centralization of penile cancer services or quaternary multi-disciplinary teams, no major clinical trials in Australia, little meaningful data, and worse outcomes for rural and indigenous men.